Shares of NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) traded down 17.8% on Tuesday . The stock traded as low as $0.21 and last traded at $0.21. 3,523 shares were traded during mid-day trading, a decline of 100% from the average session volume of 811,522 shares. The stock had previously closed at $0.25.
NexImmune Trading Down 17.8 %
The firm has a 50-day moving average price of $0.26 and a 200-day moving average price of $1.47. The stock has a market capitalization of $290,160.00, a PE ratio of -0.01 and a beta of 1.66.
NexImmune Company Profile
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Further Reading
- Five stocks we like better than NexImmune
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- What Are Growth Stocks and Investing in Them
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What Investors Need to Know About Upcoming IPOs
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
